Log in to save to my catalogue

Progestin and breast cancer risk: a systematic review

Progestin and breast cancer risk: a systematic review

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4706804

Progestin and breast cancer risk: a systematic review

About this item

Full title

Progestin and breast cancer risk: a systematic review

Publisher

New York: Springer US

Journal title

Breast cancer research and treatment, 2016-01, Vol.155 (1), p.3-12

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

This systematic review summarizes research on the use of progestin and breast cancer risk. Although mainly used for contraception, progestin can help treat menstrual disorders, and benign breast, uterine, and ovarian diseases. Breast cancer is the leading site of new, non-skin, cancers in females in the United States, and possible factors that may...

Alternative Titles

Full title

Progestin and breast cancer risk: a systematic review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4706804

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4706804

Other Identifiers

ISSN

0167-6806

E-ISSN

1573-7217

DOI

10.1007/s10549-015-3663-1

How to access this item